VC  Pontifax

http://www.pontifaxagtech.com/





     Office Locations:

2025 S Westgate Ave, First Floor
Los Angeles, CA 90025
Phone: 323-306-9970

 

Stages:

  • Early
  • Growth


 

Industries:

  • Food & Agriculture

  •  

    Description:

    Pontifax Global Food and Agriculture Technology Fund (Pontifax AgTech) is a growth capital investor in food and agriculture technology. The firm invests globally in growing businesses that improve agricultural productivity, nutrition, health, sustainability and supply chain efficiency. The following are selected areas of interest for their fund: Life Sciences, Food and Nutrition, Information Technology, Precision Farming, and Supply Chain. Pontifax Group is Israel's top life sciences investment firm. Created by TEVA founder Eli Hurvitz in 2004, Pontifax Group has invested over $350M across 4 different funds into over 45 portfolio companies. Pontifax AgTech is the first AgTech and fifth life sciences fund of Pontifax Group. The firm's 6 investment professionals have made 11 portfolio investments.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Ben Belldegrun Managing Partner and Co-Founder
    Gil Demeter Vice President
    Phil Erlanger Managing Partner and Co-Founder
    Tim Bluth Vice President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/13/2021


      Antios Therapeutics


      GA


      $96,000,000


      Series B


      04/13/2021


      Theseus Pharmaceuticals


      MA


      $100,000,000


      Series B


      03/16/2021


      StrideBio


      NC


      $81,500,000


      Series B


      02/06/2021


      Pairwise Plants


      NC


      $90,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: